For decades, scientists have been trying to find potential drugs to serve as male contraceptives to no avail. Now, a new male contraceptive could finally be within grasp with the discovery of a dual protein linked to sperm ejaculation.
Novartis scientists, in collaboration with an international team of researchers from the University of California, San Diego, and Columbia University, have identified a novel drug target for treating malaria, a scourge of many tropical Third World countries.
In a discovery that could put a vaccine for hepatitis C closer in sight, researchers have been able to characterize a key protein in the virus that aids infection in the liver.
The environment that exists inside a person's intestines may impact the effectiveness of cancer therapy, according to new research by investigators at the National Cancer Institute and France's Gustave Roussy Institute.
Using RNA interference technology, scientists have discovered a network of genes that could serve as new therapeutic targets for Parkinson's disease as well as other diseases characterized by mitochondrial damage.
Canada's Tekmira Pharmaceuticals ($TKMR) has unveiled new data showing that its antiviral RNA interference therapeutics were effective at abolishing Ebola and Marburg viruses in preclinical studies when treatment was delayed.
A cellular pathway interaction that plays a role in repairing serious injuries may also be a promising target for preventing the spread of a deadly type of brain cancer, according to a new study.
By targeting a family of proteins on the surface of certain cells, scientists have been able to halt and reverse tissue scarring in liver, kidneys and lungs in mice.
Scientists at the Cambridge, MA, startup Sage Therapeutics have discovered an innate mechanism that indirectly influences a key receptor linked to a number of neurologic and psychiatric disorders, including Alzheimer's, schizophrenia, autism and depression.
Scientists have unraveled one of the mysteries of HIV--they've mapped out the structure of an envelope protein within the virus, long known as an extremely difficult target.